BioAtla, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
BioAtla is a biotechnology company focused on developing protein therapeutics for cancer, drawing on discovery and evolution to create safer, more potent treatments. Its Conditionally Active Biologics approach enables antibodies and other biologics to activate selectively under the tumor microenvironment, with the aim of reducing on-target toxicity and improving the therapeutic index. The firm pursues these capabilities in its own development programs and through partnerships, supported by a substantial patent portfolio that includes more than 150 issued patents and patent applications. Based in San Diego, California, BioAtla operates as a relatively small research-focused biotechnology company. Notable recent developments include an exclusive worldwide license with Context Therapeutics announced in 2024 to co-develop BA3362. In 2025, the company has participated in major oncology conferences to present clinical data from ongoing trials.